kolaviron has been researched along with Cardiac Toxicity in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Farombi, EO; Olopade, JO; Omobowale, TO; Oyagbemi, AA | 1 |
| Adaramoye, OA; Lawal, SO | 1 |
2 other study(ies) available for kolaviron and Cardiac Toxicity
| Article | Year |
|---|---|
Kolaviron and Garcinia kola attenuate doxorubicin-induced cardiotoxicity in Wistar rats.
Topics: Animals; Antineoplastic Agents; Antioxidants; Cardiotoxicity; Doxorubicin; Flavonoids; Garcinia kola; Heart Rate; Humans; Male; Oxidative Stress; Plant Extracts; Rats; Rats, Wistar; Seeds | 2017 |
Kolaviron, a biflavonoid fraction from Garcinia kola, protects against isoproterenol-induced injury by mitigating cardiac dysfunction and oxidative stress in rats.
Topics: Animals; Antioxidants; Cardiotonic Agents; Cardiotoxicity; Dose-Response Relationship, Drug; Flavonoids; Garcinia kola; Isoproterenol; Male; Oxidative Stress; Quercetin; Rats; Rats, Wistar; Seeds | 2015 |